eFFECTOR Therapeutics, Inc.
EFTRDelisted Jul 19, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001828522
eFFECTOR Therapeutics, Inc. was delisted on Jul 19, 2024; its insiders filed their last Form 4 on Jun 13, 2024; 18 institutions reported holding it in 13F filings for Q2 2024, worth $251.1K in total; no superinvestor held it.
Q4 2024 vs. Q3 2024
How the institutions holding eFFECTOR Therapeutics, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 3 | 0 | −3 |
| Shares | 114.2K | 0 | −114.2K (−100.0%) |
| Value | $4.33K | $0 | −$4.33K (−100.0%) |
New holders (0)
Institutions that held eFFECTOR Therapeutics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
None.
Sold out (3)
Institutions that held eFFECTOR Therapeutics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Sabby Management, LLC | 61,758 | $2.29K |
| Blackstone Group Inc. | 52,343 | $2.04K |
| Barclays PLC | 100 | $4 |